XML 45 R23.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

SEGMENT AND GEOGRAPHIC INFORMATION

12 Months Ended

Dec. 31, 2019

Segment Reporting [Abstract]

SEGMENT AND GEOGRAPHIC INFORMATION

SEGMENT AND GEOGRAPHIC INFORMATION

The Company internally manages two global reportable segments and reports the results of its businesses to its chief operating decision maker. The two reportable segments and their activities are described below.

• The Codman Specialty Surgical segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the precision tools and instruments business, which sells more than 40,000 instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.

• The Orthopedics and Tissue Technologies segment includes such offerings as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair products.

The Corporate and other category includes (i) various executive, finance, human resource, information systems and legal functions, (ii) brand management, and (iii) share-based compensation costs.

The operating results of the various reportable segments as presented are not comparable to one another because (i) certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions, and (ii) the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. Net sales and profit by reportable segment for the years ended December 31, 2019, 2018 and 2017 are as follows:

	Years Ended December 31,
	2019				2018				2017
	(In thousands)
Segment Net Sales
Codman Specialty Surgical	$	996,206			$	963,929			$	720,301
Orthopedics and Tissue Technologies	521,351				508,512				467,935
Total revenues	$	1,517,557			$	1,472,441			$	1,188,236
Segment Profit
Codman Specialty Surgical	$	395,019			$	363,336			$	292,971
Orthopedics and Tissue Technologies	144,638				149,510				129,697
Segment profit	539,657				512,846				422,668
Amortization	(27,028)				(21,160)				(20,370)
Corporate and other	(418,869		)		(380,688		)		(357,494		)
Operating income	$	93,760			$	110,998			$	44,804

The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment.

The Company attributes revenue to geographic areas based on the location of the customer. Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below:

	United States*				Europe				Asia Pacific				Rest of the World				Consolidated
	(In thousands)
Total revenue, net:
2019	$	1,077,379			$	197,468			$	157,391			$	85,319			$	1,517,557
2018	1,045,887				201,354				144,253				80,947				1,472,441
2017	894,260				150,147				80,636				63,193				1,188,236
Total long-lived assets:
2019	$	383,652			$	47,325			$	8,598			$	7,143			$	446,718
2018	280,382				32,679				3,765				3,203				320,029

* Includes long-lived assets in Puerto Rico.

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI http://asc.fasb.org/topic&trid=2134510

+ Details

Name:	us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration